baber/WOPTO huggingface dataset:
Patent DK-0414374-T3 (DK)
Inventor: COMBERBACH MARTIN
IPC: A61K39/29
Filed: 1990-07-19
Granted: 1998-03-09
Abstract: A composite particle comprising at least two polypeptides corresponding to all or part of a protein having the biological activity of one of the hepatitis B surface antigens, wherein the particle presents at least two antigenic determinants provided by the S-protein, preS2-protein or preS1-protein, said particle optionally further comprising host specific lipids. The invention also provides a modified hepatitis B surface antigen L protein which may be used alone or incorporated into such composite particles. A particular embodiment of the modified L protein (L*) comprises residues 12-52 followed by residues 133-145 followed by residues 175-400 of the L protein and a particular embodiment of a composite particle has the form (L*, S) where S is the S-protein of HBsAg. Improved hepatitis B vaccines may be prepared following expression of the above immunogens, especially in yeasts such as  S. cerevisiae and Hansenula polymorpha.
Patent DK-0406213-T3 (DK)
Inventor: KOECKENBAUER MANFRED
IPC: A47J43/20
Filed: 1990-04-12
Granted: 1994-02-07
Abstract: The invention relates to a process for the production of preservable bakery products made of a stirred or beaten cake dough, in which a baking dish (1) made of glass or ceramic is filled up to about 80% with the dough, the baking dish (1) is then closed by a lid, the dough is then subjected to heating, the gases thereby occurring being allowed to escape, the dough is then allowed to cool, negative pressure arising in the interior of the baking dish (1). In order to achieve bakery products which are preservable for a particularly long time in a simple manner, provision is made for the entire heating operation to take place with the lid (2) closed and for the negative pressure to occur due to the cooling of the baked product, as a result of which an air-tight closure of the lid (2) is achieved without additional action, and the water activity of the finished product is kept at a value between 0.5 and 0.85, preferably between 0.6 and 0.8 due to the recipe of the bakery products and the duration and temperature of the heating operation. <IMAGE>
Patent DK-0558475-T3 (DK)
Inventor: LADING PIA
IPC: A61K47/44
Filed: 1990-11-21
Granted: 1995-04-24
Abstract: Controlled delivery of biologically active agents such as pharmaceuticals to body sites is accomplished by combination with a monoglyceride and a vegetable oil. Upon contact with an aqueous liquid, the composition forms a reverse hexagonal liquid crystalline phase matrix which releases the active agent in controlled fashion. The method of delivery is particularly useful for the treatment of periodontal disease by insertion of the liquid crystalline phase precursor composition directly into the periodontal pocket, where water from the gingival fluid induces the spontaneous in situ formation of the reverse hexagonal liquid crystalline phase matrix.
Patent DK-0554019-T3 (DK)
Inventor: ERDOS GEORGE
IPC: H01L23/485
Filed: 1993-01-22
Granted: 1999-06-21
Abstract: A bump structure for bonding leads to a semi-conductor, in which the bump has a thin lower portion (32) which overlaps and seals the edges of the passivation layer (18), and a thicker upper or stem portion (38) of smaller lateral dimensions to fit within the margins of the opening in the passivation layer. Thus, during bonding, downward compressive forces are applied primarily through the bump stem directly to the metal termination pad (14) beneath the bump, and very little force is applied to the edges of the passivation layer. This reduces the likelihood of passivation layer cracking, increasing device reliability. Because the bump stem is formed within the margins of the passivation layer opening, it has a flat top, resulting in better lead bonding. <IMAGE>
Patent DK-0627933-T3 (DK)
Inventor: HAFLER DAVID A
IPC: A61K38/095
Filed: 1993-02-25
Granted: 2003-03-24
Abstract: The invention is directed to a method of treating a T cell-mediated autoimmune disease in animals, including humans, by the oral or enteral administration of autoantigens, fragments of autoantigens, or analogs structurally related to those autoantigens, which are specific for the particular autoimmune disease. The method of the invention includes both prophylactic and therapeutic measures.
Patent DK-0635088-T3 (DK)
Inventor: BAILEY MICHAEL LEONARD
IPC: E04B1/14
Filed: 1993-04-08
Granted: 2001-02-26
Abstract: A rectilinear composite building panel having a pair of opposed faces, and a pair of opposed sides, the panel comprising a pair of spaced-apart rigid face sheets (56), a rigid insulating material (58) sandwiched between, and adhering to, the face sheets, connecting means (60) connecting the face sheets together to resist relative movement between the face sheets in the plane of the panel and out of the plane of the panel; the opposed sides (66, 70) each have a profiled shape for mating with a correspondingly profiled side of an adjacent panel; each side (66, 70) has means (72, 74) for securing, or being secured to, a side of an adjacent panel of the same general construction. The panels can be easily assembled together to form a fire-resistant multi-storey building. <IMAGE>
Patent DK-0633289-T3 (DK)
Inventor: BRAGA VITTORIO
IPC: C08J9/00
Filed: 1994-07-07
Granted: 1999-07-05
Abstract: Partially cross-linked polyolefin compositions are disclosed, which are prepared by dynamic cross-linking and comprise (percentages by weight):     1) 5-50% of a crystalline propylene homopolymer or copolymer; 2) 50-95% of a partially cross-linked elastomeric polymer partially soluble in xylene at ambient temperature, containing ethylene, propylene and/or another  alpha -olefin. Said compositions contain from 20% to 92% of a fraction soluble in xylene at ambient temperature, wherein the ethylene is present in quantities lower than or equal to 35%.
Patent DK-0643410-T3 (DK)
Inventor: BONILLO HERNANDEZ JORGE J
IPC: H01H50/44
Filed: 1994-09-06
Granted: 1998-09-23
Abstract: Improved relay which consists of a carcass (1) fitted with a lower closure base (2), while, within the assembly, there is a mechanism consisting of an electromagnet (5) and of a metal part (6) which is arranged in a tilting mounting on a respective support part (7), the said part (7) being fixed by the part (15) constituting the core of the electromagnet (5), while the tilting part (6) is drawn back, by means of a spring (8) arranged on this part and on a respective base part (9), in which the body (10), provided for the corresponding coil (11) of the electromagnet (5) is defined as a unit. <IMAGE>
Patent DK-0677026-T3 (DK)
Inventor: GULDBERG MARIANNE
IPC: A01G31/00
Filed: 1993-12-21
Granted: 1998-03-09
Abstract: PCT No. PCT/DK93/00435 Sec. 371 Date Jun. 21, 1995 Sec. 102(e) Date Jun. 21, 1995 PCT Filed Dec. 21, 1993 PCT Pub. No. WO94/14717 PCT Pub. Date Jul. 7, 1994A fiberizable mineral composition which is thermostable and has a high dissolution rate in biological fluids includes 53.5-64 w/w % of SiO2, up to 4 w/w % of Al2O3, 10-20 w/w % of CaO, 10-20 w/w % of MgO, and 6.5-9 w/w % of FeO, the total amount of FeO and Fe2O3 calculated as FeO. A mineral fiber material made from the composition can be used for thermal and/or acoustic insulation purposes or as a plant growing medium or substrate.
Patent DK-0644782-T3 (DK)
Inventor: BRYANT ROBERT J
IPC: A61M5/00
Filed: 1994-02-28
Granted: 1999-08-02
Abstract: The system has an alarm system which reacts differently to different abnormal conditions. In more serious conditions dialysis operation is suspended and user intervention is required to resume operation. Where a less serious abnormal condition occurs, the dialysis operation is allowed to continue for a certain time and, only if the condition persists, is the operation suspended. <IMAGE>
Patent DK-0690712-T3 (DK)
Inventor: HOLTON ROBERT A
IPC: C07F7/18
Filed: 1994-03-21
Granted: 2002-03-18
Abstract: Taxane derivatives having a pyridyl substituted C13 side-chain.
Patent DK-0710099-T3 (DK)
Inventor: WEINBERGER ERIC PATTON
IPC: D04H1/42
Filed: 1994-07-22
Granted: 1999-06-14
Abstract: The present invention relates to absorbent articles such as sanitary napkins, panty liners, and incontinence pads. More particularly, the present invention relates to absorbent articles, such as sanitary napkins, that have undergarment covering components (or "side wrapping elements") that automatically wrap the sides of a wearer's panties and provide an alternative to conventional side flaps. The side wrapping elements have at least one zone of extensibility and at a region therein that is stiffer than the zone of extensibility.
Patent DK-0787104-T3 (DK)
Inventor: SWART ANNELIES
IPC: B65D85/50
Filed: 1995-08-15
Granted: 1999-03-08
Abstract: PCT No. PCT/NL95/00272 Sec. 371 Date Jun. 4, 1997 Sec. 102(e) Date Jun. 4, 1997 PCT Filed Aug. 15, 1995 PCT Pub. No. WO96/12662 PCT Pub. Date May 2, 1996The object of this invention is to provide a package for flowers, candy or other consumables or objects which can easily be transformed from a first, transport configuration into a second, stationary configuration, is stable in its stationary configuration and can be manufactured exclusively out of thin walled material such as (biodegradable) plastic board or fiber board. Transformation from the transport configuration into the stationary configuration can easily be accomplished by detaching the upper part from the lower part along a weakened line delimitating the upper and the lower part when the package is in transport condition. Then the lower part is inserted into the upper part, which preferably has to be inverted first so that the generally relatively wide upper end of the upper part faces downward and forms the new lower end until the lower part is supported by the lower end of the upper part.
Patent DK-0773756-T3 (DK)
Inventor: SCHUMACHER BRIAN
IPC: A61F2/38
Filed: 1995-08-01
Granted: 2003-02-24
Abstract: A knee prosthesis includes a femoral prosthesis member having anterior, distal, and posterior articulating surface portions. The posterior articulating surface portions comprising a pair of condylar surface portions that are positioned at differing distances from the anterior non-articulating surface plane. The posterolateral articulating surface is a greater distance away from the anterior non-articulating surface than the posteromedial articulating surface. The femoral prosthesis has a non-articulating surface that includes a plurality of intersecting surfaces including at least distal, anterior, and posterior surfaces for receiving the patient's distal femur after it has been surgically prepared. A tibial component has concave articulating surfaces that receive the femoral component articulating surface portions during use. The angle of femoral rotation generally about the mechanical axis generally changes when going through a normal range of motion of the patient's knee while maintaining alignment of the femoral and tibial articular surfaces. The femoral prosthesis also has a proximal anterior region that is concave.
Patent DK-0800568-T3 (DK)
Inventor: TIITTA MARJA
IPC: C10G50/00
Filed: 1995-12-20
Granted: 2001-12-17
Abstract: The invention relates to a process for the oligomerization of light alkenes, in particular butenes, for the preparation of diesel oil and lubricating oil fractions having an improved cetane number and an improved viscosity index, in the presence of a chromium-containing ZSM-5 zeolite catalyst in temperature and pressure conditions which maintain oligomerization. The catalyst used in the process is an HZSM zeolite to which chromium in an amount of 0.7-5 wt.% of the weight of zeolite has been added by the impregnation technique or the dry ion exchange technique.
Patent DK-0745690-T3 (DK)
Inventor: TYAGI SANJAY
IPC: C07H21/04
Filed: 1996-05-10
Granted: 2009-01-12
Abstract: Unimolecular and bimolecular hybridization probes for the detection of nucleic acid target sequences comprise a target complement sequence, an affinity pair holding the probe in a closed conformation in the absence of target sequence, and either a label pair that interacts when the probe is in the closed conformation or, for certain unimolecular probes, a non-interactive label. Hybridization of the target and target complement sequences shifts the probe to an open conformation. The shift is detectable due to reduced interaction of the label pair or by detecting a signal from a non-interactive label. Certain unimolecular probes can discriminate between target and non-target sequences differing by as little as one nucleotide. Also, universal stems and kits useful for constructing said probes. Also, assays utilizing said probes and kits for performing such assays. Also, such probes capable of allelic discrimination.
Patent DK-0743300-T3 (DK)
Inventor: LEBRETON LUC
IPC: A61K38/06
Filed: 1996-05-03
Granted: 2000-01-24
Abstract: 15-Deoxy-spergualin carbamate analogues of formula NH2-C(=NH)NH(CH2)6ACH2NHCO-O-(CH2)4NH(CH2)2-*CH(R)-NH2</ SB> (I) and their addn. salts are new. A=CONH or NHCO; R=H or Me; if R is other than H, *C has (R,S) or (R) configuration. Intermediates of formulae NHR1-C(=NR1)NH(CH2)6ACH2NHCO-O-(CH2)4N(R1)(CH2) 2-*CH(R)-NHR1 (II) and HO-(CH2)4-NR1-(CH2)2-*CH(R)-NHR1 (III; R=Me) are also new.
Patent DK-0810889-T3 (DK)
Inventor: LAZAROV MILADIN P
IPC: C23C14/06
Filed: 1996-02-22
Granted: 2001-10-22
Abstract: PCT No. PCT/DE96/00322 Sec. 371 Date Feb. 9, 1998 Sec. 102(e) Date Feb. 9, 1998 PCT Filed Feb. 22, 1996 PCT Pub. No. WO96/25960 PCT Pub. Date Aug. 29, 1996The present invention relates to an implant for use in the human body, an implant substrate being coated with a material which contains chemical compounds between one or more metals (M) of group IV A of the periodic system, nitrogen (N) and oxygen (O), 2 to 45% of the volume in the coating material being formed by voids whose sizes range from (0.4 nm)3 to (50 nm)3, and the remaining volume having a composition of a metal of group IV A of the periodic system to nitrogen to oxygen of 1:(0.1 to 1.7):(0.1 to 1.7), a material having formula MNxOy (wherein x,y=0.1-1.7) resulting. The invention also relates to the use of this implant for implantation into the animal or human body.
Patent DK-0850070-T3 (DK)
Inventor: ZHAO QIUYAN
IPC: A61K47/48
Filed: 1996-08-19
Granted: 2003-04-22
Abstract: The present invention provides a method of reducing the immunostimulatory effects of certain phosphorothioate oligonucleotides used to treat pathogen-mediated disease states and other medical conditions. Immunostimulatory effects of phosphorothioate oligonucleotides are reduced in accordance with the method of the invention by administering the phosphorothioate oligonucleotide in a therapeutic formulation which includes at least one cyclodextrin to a mammal afflicted with the disease or condition being treated. The immune response of the mammal is also monitored in the method of the invention.
Patent DK-0790254-T3 (DK)
Inventor: FAUCHERE JEAN-LUC
IPC: A61K31/41
Filed: 1997-02-10
Granted: 2001-10-08
Abstract: Pseudopeptide neurokinin derivatives of formula (I), their enantiomers, diastereomers, epimers and acid or base addition salts are new. R1 = indolyl, naphthyl, tetrahydronaphthyl, thienyl, Ph (optionally substituted by one or more halo, 1-6C alkyl, 1-6C alkoxy, OH or trihalomethyl) or 3-7C cycloalkyl; n = 1-8; m = 1-4; and R2 = benzyl or Ph (both optionally substituted by one or more halo, 1-6C alkyl, 1-6C alkoxy, OH or trihalomethyl) or 1-6C alkyl.
Patent DK-0918797-T3 (DK)
Inventor: PONATH PAUL D
IPC: C12P21/08
Filed: 1997-08-06
Granted: 2006-07-31
Abstract: The present invention relates to humanized immunoglobulins having binding specificity for ±4²7 integrin, comprising an antigen binding region of nonhuman origin (e.g., rodent) and at least a portion of an immunoglobulin of human origin (e.g., a human framework region, a human constant region). In one embodiment, the humanized immunoglobulin can compete with murine Act-1 for binding to human ±4²7 integrin. In a preferred embodiment, the antigen binding region of the humanized immunoglobulin comprises each of the complementarity determining regions of the light and heavy chains of the murine Act-1 antibody. The present invention further relates to a humanized immunoglobulin light chain or heavy chain, isolated nucleic acids comprising a sequence which encodes a humanized immunoglobulin or immunoglobulin chain of the present invention (e.g., a single chain antibody), constructs comprising a nucleic acid of the present invention, and host cells comprising a nucleic acid of the present invention useful in a method of preparing a humanized immunoglobulin. The humanized immunoglobulins can be used in diagnostic and therapeutic applications in humans, for example to control lymphocyte infiltration (including recruitment and/or accumulation) to mucosal tissue.
Patent DK-0917526-T3 (DK)
Inventor: BARTH THOMAS
IPC: C05G3/90
Filed: 1997-08-06
Granted: 2002-03-25
Abstract: The use of inorganic or organic poly acids is claimed for treating mineral fertilisers containing a nitrification inhibitor. The use of compounds of formula (I) is claimed as nitrification inhibitors. R1 = H, halo or 1-4C alkyl; R2 = 1-4C alkyl; R3 = H or CH2OH, and when R3 = H, the compound may be converted to a phosphoric acid salt. A mineral fertiliser containing a poly acid and optionally (I) is also claimed. 3,4-dimethylpyrazole (Ia), 4-chloro-3-methyl-pyrazole (Ib), N-hydroxymethyl-3,4-dimethylpyrazole (Ic), N-hydroxymethyl-4-chloro-3-methylpyrazole (Id), acid addition salts of (Ic) and (Id), and mixtures of two or more of (Ia)-(d) are new.
Patent DK-1048100-T3 (DK)
Inventor: BERGER FRANK
IPC: H02B13/075
Filed: 1998-10-15
Granted: 2005-11-07
Abstract: Ein Kurzschliesser für eine Störlichtbogen-Schutzvorrichtung zur Verwendung in Anlagen zur Verteilung elektrischer Energie mit einem Gasgenerator und ein direkt von dem Gasgenerator angetriebenes kurzschliessendes Element soll aus wenigen Komponenten bestehen, klein, relativ leicht, wartungsarm, leicht anschliessbar und für hohe Ströme und Spannungen geeignet sein. Dies wird dadurch erreicht, dass der Kurzschliesser (1) aus einem sandwichartigen Paket aus Stromschienen und mindestens einer dünnen Isolierfolie (31) besteht, wobei die Stromschienen bei einer Zündung durch das kurzschliessende Element nach einem Durchstanzen oder Durchstossen der Isolierfolie (31) kurzgeschlossen werden.
Patent DK-1035860-T3 (DK)
Inventor: BOHACH GREGORY I
IPC: C07K2/00
Filed: 1998-12-01
Granted: 2006-09-18
Abstract: Pyrogenic toxins, such as staphylococcal enterotoxins, modified in the disulfide loop region are provided. The modified toxins retain useful biological properties but have substantially reduced toxicity compared to the corresponding unmodified native toxin. The native pyrogenic toxins are typically modified by deletions within the disulfide loop region to produce modified enterotoxins having 100-fold or greater decrease in toxicity.
Patent DK-0973332-T3 (DK)
Inventor: OSTROVER LEWIS S
IPC: G11B27/32
Filed: 1994-10-13
Granted: 2001-10-29
Abstract: A system for playing a selected one of multiple subtitle tracks recorded in a synchronized fashion with a motion picture on an optical disk (23). Individual subtitle tracks in numerous languages may be provided for the same motion picture, with or without multiple soundtracks. The user may select a soundtrack in his/her language if it is available. If not, subtitles can be displayed in a selected language.
Patent DK-0997974-T3 (DK)
Inventor: ISOHAETAELAE ANNE
IPC: H01Q5/357
Filed: 1999-09-29
Granted: 2002-03-04
Abstract: A planar antenna comprises a planar radiating element (600) formed of a conductive area confined by a substantially continuous border line. The conductive area is split by a gap which divides the planar radiating element into a first branch and second branch such that both the first and the second branch have an outermost end. The gap has a head end on said substantially continuous border line and a tail end within the conductive area. At its head end (601) the gap has a certain first direction and at another point (603) a certain second direction which differs from the first direction by more than 90 degrees when the directions are defined along the gap from the head end towards the tail end. The outermost end of the second branch, confined by the gap, is located within the continuous border line, surrounded by the first branch. <IMAGE>
Patent ES-2245912-T3 (ES)
Inventor: BREDY THIERRY
IPC: G08B15/00
Filed: 2000-02-03
Granted: 2006-02-01
Abstract: The zone defence mechanism has an inflatable bag (11) mounted on a fixed platform (2). The bag is flexible and inflated by a gas or fluid generator (9) which is switched by a command (14). The envelope is deployed above the platform on inflation hindering the progress of the intruder.
Patent ES-2325200-T3 (ES)
Inventor: LOU JIANFENG
IPC: C08F2/38
Filed: 2000-09-08
Granted: 2009-08-28
Abstract: The present invention is a composition for and a method of shortstopping free radical emulsion polymerizations that inhibits the formation of nitrosamines. The composition comprises nitrosamine inhibitors in combination with conventional alkylhydroxylamine shortstoppers. Such nitrosamine inhibitors are based on primary amines, amine-containing polymers, pyrroles, hydroquinones, certain phenols, ascorbic acid, and other well-known nitrosation inhibitors; they may be used individually or as a blend. The compositions are targeted for applications in the emulsion processes for producing rubber latexes and the preparation of rubber products thereafter.
Patent ES-2212973-T3 (ES)
Title: Dispositivo antivibratorio de absorcion de par.
Inventor: DANDRE JACQUES
IPC: F16F1/387
Filed: 2000-04-04
Granted: 2004-08-16
Abstract: Dispositivo antivibratorio de absorción de par destinado destinado a unir un motor (1) a un chasis (2) de vehículo con el fin de limitar los desplazamientos del motor según por lo menos una primera dirección (X), comprendiendo este dispositivo de absorción de par: - unas primera y segunda armaduras rígidas (9, 11) que están destinadas a ser fijadas una al motor, y la otra al chasis, delimitando la segunda armadura (11) un espacio interior hueco (12) en el cual está dispuesta la primera armadura (9), con un cierto juego en la primera dirección (X) y en unas segunda y tercera direcciones (Z, Y1) perpendiculares entre sí y perpendiculares a dicha primera dirección, - un primer conjunto de limitación (15) de elastómero que está adherido sobre la segunda armadura (11) e interpuesto entre las primera y segunda armaduras para limitar sus desplazamientos relativos en la primera dirección (X), según un primer sentido (4) correspondiente a un desplazamiento sufrido por el motor (1) cuando produce una fuerza motriz, presentando el primer conjunto de limitación (15) un primer espesor de elastómero (L1) en el espacio interior (12) de la segunda armadura, medido según la primera dirección (X), - y un segundo conjunto de limitación (16) de elastómero que está adherido sobre la segunda armadura (11) e interpuesto entre las primera y segunda armaduras (9, 11) para limitar sus desplazamientos relativos en la primera dirección (X), según un segundo sentido (5) opuesto a dicho primer sentido y correspondiente al desplazamiento sufrido por el motor (1) cuando produce una deceleración, presentando el segundo conjunto de limitación (16) un segundo espesor de elastómero (L2) en el espacio interior (12) de la segunda armadura, medido según la primera dirección. caracterizado porque la primera armadura (9) presenta una forma sensiblemente aplanada en las segunda y tercera direcciones (Z, Y1), porque la primera armadura (9) está simplemente insertada entre los primer y segundo conjuntos de limitación(15, 16) de elastómero, sin adhesión entre la primera armadura y dichos primero y segundo conjuntos de limitación, y porque el primer espesor de elastómero (L1) es superior al segundo espesor de elastómero (L2).